Following a four day bench trial in a consolidated ANDA action before The Honorable Gregory M. Sleet in Genzyme Corp., et al. v. Dr. Reddy’s Laboratories, Ltd., et al., Civil Action Nos. 13-1506 and 13-1508-GMS (D.Del., May 11, 2016), the Court issued its findings of fact and conclusions of law pursuant to Federal Rule of Civil Procedure 52(a) and specifically concluded that Defendants failed to establish by clear and convincing evidence that claim 19 of U.S. Patent No. 7,897,590 (“the ‘590 patent”) is invalid due to obviousness.
A copy of the Memorandum setting forth the Court’s findings of fact and conclusions of law is attached.